T2 Biosystems is focused on addressing critical unmet needs in healthcare starting with sepsis, one of the deadliest and most expensive conditions in hospitals today. The T2Dx Instrument and T2Candida Panel have received marketing authorization from ...
As you can see below, T2 Biosystems had US$46.5m of debt, at June 2021, which is about the same as the year before. You can click the chart for greater detail. However, it does have US$52.8m in
Phone Number 7814571216 T2 Biosystems is a private company developing a next-generation medical diagnostic platform that will enable rapid and accurate diagnostic tests of all types on a single, easy to use instrument.
LEXINGTON, Mass., Dec. 03, 2015 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) today announced the pricing of its underwritten public offering of 3,500,000 shares of common stock at a public offering price of $9.75 per share, before underwriting discounts, for gross proceeds of $34,125,000.In addition, T2 Biosystems has granted the ...
T2 Biosystems CS (TTOO) Company Description T2 Biosystems Inc provides rapid in vitro diagnostic tests to hospitals and laboratories. The company's core technology is T2 Magnetic Resonance (T2MR) technology, which can detect a variety of molecular targets directly from whole blood.
At T2 Biosystems, our mission is to save lives and improve healthcare by empowering clinicians to get patients on the right therapy faster. We come to work every day to solve critical needs in healthcare diagnostics with innovative solutions built on our game-changing T2 Magnetic Resonance (T2MR®) detection technology.
+1 (781) 000-0000 Contact Information Website www.t2biosystems.com Ownership Status Publicly Held Financing Status Formerly VC-backed Primary Industry Diagnostic Equipment Stock Exchange NAS Primary Office 91 Hartwell Avenue Lexington, MA 02421 United States +1 (781) 000-0000 Want detailed data on 3M+ companies? What you see here scratches the surface